Apollo Health Ventures is a transatlantic early-stage Venture Capital firm actively co-founding and investing in transformative healthcare companies. Their primary focus is on companies targeting age-related diseases and aging itself. They believe that biotechnology is the solution for a healthier lifespan and reduced healthcare spending. They aim to impact human health within the next 10 years by enabling transformative healthcare companies in their scientific breakthroughs. The firm leverages a Venture Lab to identify company-building opportunities and maintains close ties with leading research institutions and researchers in the aging sector.
Bevorzugte Reifephase für die erste Finanzierung.
Age-related diseases, aging, biotechnology, therapeutics, health tech, oncology, inflammatory diseases, fibrotic diseases, neurodegenerative diseases
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Standard-Finanzierungsbetrag pro Runde.
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...